Results 191 to 200 of about 693,536 (346)

Effect of Fluoride on Gut Microbiota: A Systematic Review. [PDF]

Nutr Rev
Yasin M, Zohoori FV, Kumah EA, Subramanian M, Dean P, Orr CH.   +5 more
europepmc   +1 more source

Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa

Proceedings of the National Academy of Sciences of the United States of America, 2010
C. de Filippo, D. Cavalieri, M. di Paola, M. Ramazzotti, J. Poullet, S. Massart, S. Collini, G. Pieraccini, P. Lionetti   +8 more
semanticscholar   +1 more source

Feasibility and population exposure of 5‐fluorouracil using therapeutic drug monitoring (PREDICT‐5FU): A multicentre clinical trial

British Journal of Clinical Pharmacology, EarlyView.
Aim PREDICT‐5FU aimed to document 5‐fluorouracil (5FU) exposure in a cancer population and to evaluate the feasibility of 5FU and capecitabine therapeutic drug monitoring (TDM) in patients receiving standard doses and schedules. Methods Multicentre, prospective, observational single‐arm study.
Sarah Glewis, Michael Michael, Howard Gurney, Ian Olver, Nicholas Zdenkowski, Stephen Ackland, Craig Kukard, Madawa Jayawardana, S. Sandun M. Silva, Marliese Alexander, Jeanne Tie, Peter Galettis, Jennifer H. Martin   +12 more
wiley   +1 more source

Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders [PDF]

, 2010
Giovanni Musso, Roberto Gambino, Maurizio Cassader   +2 more
openalex   +1 more source

Gut microbiota in hepatocellular carcinoma immunotherapy: immune microenvironment remodeling and gut microbiota modification. [PDF]

Gut Microbes
Huang M, Ji Q, Huang H, Wang X, Wang L.
europepmc   +1 more source

Host-Gut Microbiota Metabolic Interactions

Science, 2012
J. Nicholson, E. Holmes, J. Kinross, R. Burcelin, G. Gibson, W. Jia, S. Pettersson   +6 more
semanticscholar   +1 more source

Variability in intestinal drug metabolizing enzymes and transporters in Crohn's disease and potential impact on oral drug absorption

British Journal of Clinical Pharmacology, EarlyView.
Aims The aim of study was to generate quantitative data on the abundance of drug‐metabolizing enzymes and transporters (DMETs) in inflamed and non‐inflamed Crohn's disease (CD) ileum and colon, for incorporation into physiologically based pharmacokinetic (PBPK) models, enabling prediction of oral drugs' pharmacokinetics (PK) perturbation in CD patients.
Sarah Alrubia, Brahim Achour, Zubida M. Al‐Majdoub, Amin Rostami‐Hodjegan, Jill Barber   +4 more
wiley   +1 more source

Faculty Opinions recommendation of Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients.

, 2008
Silvana Curci
openalex   +2 more sources

Gut Microbiota is Not Modified by Randomized, Double-Blind, Placebo-Controlled Trial of VSL#3 in Diarrhea-Predominant Irritable Bowel Syndrome [PDF]

, 2010
Sonia Michail, Harshavardhan Kenche
openalex   +1 more source

Seasonal Variation in the Diversity of the Gut Microbiota of Short-Faced Moles Reveals the Associations of Climatic Factors on the Gut Microbiota of Subterranean Mammals. [PDF]

Ecol Evol
Xu D, Wu M, Gao Z, Zhao Y, Hu M, Wen Y, Wang L, Xu D, Chen L.   +8 more
europepmc   +1 more source